Metadate CD is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD). It contains methylphenidate, the same active ingredient found in Ritalin, but is designed as an extended-release capsule that works for roughly 8 to 10 hours on a single morning dose. The FDA has approved it specifically for children and adolescents ages 6 to 15.
How Metadate CD Works
Methylphenidate increases the activity of certain brain chemicals involved in focus, attention, and impulse control. What makes Metadate CD different from a standard methylphenidate tablet is its two-phase release system. Each capsule contains two types of tiny beads: about 30% of the beads dissolve right away, delivering an initial dose that kicks in quickly, while the remaining 70% dissolve hours later, providing a second wave of medication during the afternoon.
This biphasic design is meant to mimic what would happen if you took a short-acting methylphenidate pill in the morning and another one at lunchtime, but without needing that second dose. For school-age children, that means no trip to the nurse’s office for a midday pill. The total effect lasts approximately 8 to 10 hours, covering the school day and after-school homework time before wearing off in the evening.
Available Strengths and Dosing
Metadate CD comes in extended-release capsules at six strengths: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg. The typical starting dose is 20 mg taken once each morning. From there, the dose can be adjusted upward by 10 to 20 mg per week based on how well it’s working and how well it’s tolerated. The maximum recommended dose is 60 mg per day.
For children who have trouble swallowing capsules, the capsule can be opened and the beads sprinkled onto a small amount of soft food like applesauce. The beads should be swallowed without chewing, since crushing them would destroy the extended-release design and release the full dose at once.
How It Compares to Similar Medications
Metadate CD is one of several extended-release methylphenidate products on the market. Ritalin LA is the most direct comparison, since both are capsules containing two types of beads and both last about 8 to 10 hours. The key difference is in how the medication is split between the two phases. Metadate CD delivers 30% of its dose immediately and 70% later, while Ritalin LA uses a 50/50 split. In practice, this means Metadate CD provides a somewhat smaller initial boost and a larger sustained dose through the afternoon, whereas Ritalin LA delivers equal amounts in each phase.
Longer-acting options like Concerta use a different mechanism and can last up to 12 hours, which may be preferable for older teens or anyone who needs coverage into the evening. Shorter-acting tablets like standard Ritalin last only 3 to 4 hours and require multiple doses throughout the day. The choice between these products often comes down to how long coverage is needed and how a child responds to different release patterns.
Common Side Effects
The side effects of Metadate CD are typical of stimulant medications. The most frequently reported issues include decreased appetite, trouble sleeping (especially if the medication is taken too late in the day), headache, and stomach pain. Some children experience irritability or mood changes as the medication wears off in the late afternoon, sometimes called the “rebound effect.”
Stimulants can also raise heart rate and blood pressure slightly. In most children these increases are minor, but they’re worth monitoring, especially in anyone with an existing heart condition. Weight loss or slower-than-expected weight gain is another concern with long-term use, since appetite suppression can be significant. Growth should be tracked over time.
Safety Warnings
Metadate CD is classified as a Schedule II controlled substance, which is the same category as other stimulants like amphetamine-based ADHD medications. The FDA requires a boxed warning on the label (the most serious type of safety warning) stating that it carries a high potential for abuse and misuse, which can lead to addiction. The risk of harm increases when the drug is taken at higher doses than prescribed or through unapproved methods such as crushing and snorting the beads.
This classification does not mean that everyone who takes Metadate CD as prescribed will develop a problem. When used at recommended doses under medical supervision, the risk is significantly lower. However, the medication should be stored securely and any unused capsules disposed of properly, since stimulant medications are frequently targets for diversion.
Brand and Generic Availability
Metadate CD is currently manufactured by Aytu BioPharma and remains available as a brand-name product in all six capsule strengths. Generic versions of extended-release methylphenidate capsules also exist, though availability has fluctuated in recent years due to broader stimulant medication shortages affecting the U.S. market. If your pharmacy is unable to fill a specific strength, your prescriber may be able to adjust the prescription to use available alternatives or a different extended-release methylphenidate product with a similar duration.